This inventor holds 1 USPTO granted patent. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 1989.
Company Filing History:
Years Active: 1989
Title: Fumiko Hazato: Innovator in Pharmaceutical Chemistry
Introduction
Fumiko Hazato is a prominent inventor based in Ageo, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit blood platelet aggregation. Her work has implications for various medical applications, showcasing her innovative spirit and dedication to improving health outcomes.
Latest Patents
Fumiko Hazato holds a patent for 3-Oxoalkylidene-2-azetidinone derivatives, specifically 2-Azetidione derivatives. These compounds are represented by a specific formula wherein various groups can be substituted, including hydrogen atoms, halogens, and lower alkyl groups. The patent highlights the utility of these compounds as blood platelet aggregation inhibiting agents, which can be crucial in preventing thrombotic events.
Career Highlights
Throughout her career, Fumiko has been associated with Taisho Pharmaceutical Co., Ltd., where she has contributed to various research initiatives. Her innovative work has led to advancements in pharmaceutical formulations and therapeutic agents. With a total of 1 patent, she has established herself as a key figure in her field.
Collaborations
Fumiko has collaborated with notable colleagues, including Yutaka Kawashima and Masakazu Satoh. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the research output.
Conclusion
Fumiko Hazato's contributions to pharmaceutical chemistry exemplify her commitment to innovation and research. Her patent for blood platelet aggregation inhibitors highlights her role as a significant inventor in the industry. Her work continues to inspire future advancements in medical science.